Recommendations for screening of MetS: Utilizing total cholesterol for trend and prevalence estimates of Metabolic Syndrome among adults-findings from STEPS survey of Nepal
Bhawana Bhandari, Bihumgum Bista, Suna Laxmi Karmacharya, Anil Babu Ojha, Suresh Mehata, Mariani Ahmad Nizaruddin

TL;DR
This study found that the prevalence of Metabolic Syndrome in Nepal decreased from 2013 to 2019, with women being more affected, and suggests using total cholesterol for cost-effective screening.
Contribution
The study recommends using total cholesterol for MetS screening and highlights gender-specific risk factors in Nepal.
Findings
The prevalence of MetS in Nepal decreased from 14.1% in 2013 to 6.69% in 2019.
Women had a higher prevalence of MetS (8.62%) compared to men (4.57%).
High waist circumference in women and hypertension in men were key components of MetS.
Abstract
The global prevalence of Metabolic Syndrome (MetS)is rising, underscoring the significant burden of cardiovascular morbidity and mortality. Most studies on MetS focus on clinical aspects however, to reduce the burden of cardiovascular disease, periodic screening for MetS is essential along with cost-effective measures that can be implemented on a community basis. The study was a population-based retrospective cross-sectional STEPwise surveillance (STEPS) conducted in three ecological regions of Nepal in 2013 and 2019.A multistage cluster sampling technique was employed to select the sample. Altogether 3473 and 5051 participants were selected from 2013 and 2019 STEPS survey data. Anthropometric measurements, blood pressure readings and fasting blood test for chemical analysis were collected. A conventional measurement criterion was used to determine the prevalence of MetS utilizing Total…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes, Cardiovascular Risks, and Lipoproteins · HIV-related health complications and treatments · Health Promotion and Cardiovascular Prevention
